Pharmabiz3h
Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees
Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees: Our Bureau, Bengaluru Tuesday, September 17, 2024, 17:15 Hrs [IST] Novo Nord ...
Pharmabiz3h
Poseida Therapeutics’ P-BCMA-ALLO1 receives US FDA RMAT designation to treat relapsed/refractory multiple myeloma
Poseida Therapeutics’ P-BCMA-ALLO1 receives US FDA RMAT designation to treat relapsed/refractory multiple myeloma: San Diego Tuesday, September 17, 2024, 17:00 Hrs [IST] Poseida ...
Pharmabiz4h
Tata Elxsi’s ‘xG-Force’ 5G applications lab for digital transformation offers infrastructure for healthcare research
Our Bureau, Bengaluru Tuesday, September 17, 2024, 16:30 Hrs [IST] ...
Pharmabiz4h
Orchid Pharma sets up Orchid AMS division, to combat the rising threat of antimicrobial resistance
Orchid Pharma, a Chennai-based leading pharmaceutical company, announced the formation of Orchid AMS (antimicrobial solutions), a dedicated division focused on helping address the critical challenge ...
Pharmabiz4h
Phase 1 trial of DS-9606 shows promising preliminary clinical activity in patients with advanced solid tumours
Initial results from dose escalation in the first in-human phase 1 trial of DS-9606 suggest early promising clinical activity in patients with advanced solid tumours known to express Claudin-6 (CLDN6) ...
Pharmabiz4h
FIP supports education on substandard and falsified medicines sold online with new handbook
FIP supports education on substandard and falsified medicines sold online with new handbook: Our Bureau, Bengaluru Tuesday, September 17, 2024, 15:50 Hrs [IST] International Pharm ...
Pharmabiz4h
Civil Society Organisations opposes Gilead's patent applications for lenacapavir in India
Civil society organisations opposing the patent applications of US-based pharma major Gilead Sciences for the HIV drug lenacapavir have said that generic competition is needed to make the long acting ...
Pharmabiz5h
Eppendorf India and Rajalakshmi Engineering College extend MoU to enhance biotechnology training for students
Eppendorf India and Rajalakshmi Engineering College extend MoU to enhance biotechnology training for students: Our Bureau, ...
Pharmabiz6h
Accuray bridging gap of India's escalating cancer burden with latest version of Radixact radiation therapy
Accuray bridging gap of India's escalating cancer burden with latest version of Radixact radiation therapy: Our Bureau, Bengaluru Tuesday, September 17, 2024, 14:15 Hrs [IST] Accu ...
Pharmabiz6h
Tharimmune acquires global license and partners with Intract Pharma to develop an oral formulation of infliximab
Bridgewater, New Jersey Tuesday, September 17, 2024, 14:00 Hrs [IST] ...
Pharmabiz7h
Boehringer Ingelheim pivotal phase-III FIBRONEER-IPF study of nerandomilast meets primary endpoint
Boehringer Ingelheim pivotal phase-III FIBRONEER-IPF study of nerandomilast meets primary endpoint: Ingelheim, Germany Tuesday, September 17, 2024, 13:00 Hrs [IST] Boehringer Inge ...
Pharmabiz8h
Tim Leest elected as new chair for EMA’s Orphan Medicinal Products Committee
Tim Leest elected as new chair for EMA’s Orphan Medicinal Products Committee: Amsterdam, The Netherlands Tuesday, September 17, 2024, 12:00 Hrs [IST] The European Medicines Agen ...